Upgrade to SI Premium - Free Trial

Amphastar Pharmaceuticals (AMPH) PT Raised to $24 at Needham & Company

March 13, 2018 6:31 AM
Needham & Company raised its price target on Amphastar Pharmaceuticals (NASDAQ: AMPH) to $24.00 (from $23.00) while maintaining a Buy ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View Analyst PT Change

Next Articles